These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16785414)

  • 1. Epigenetic events of disease progression in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Meduri V; Nygren AO; Errami A; Schouten JP; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Jun; 132(6):668-77. PubMed ID: 16785414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA hypermethylation profiles in squamous cell carcinoma of the vulva.
    Stephen JK; Chen KM; Raitanen M; Grénman S; Worsham MJ
    Int J Gynecol Pathol; 2009 Jan; 28(1):63-75. PubMed ID: 19047905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma.
    Worsham MJ; Pals G; Schouten JP; Van Spaendonk RM; Concus A; Carey TE; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2003 Jul; 129(7):702-8. PubMed ID: 12874067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H; Geeraerts H; Verbeken E; Nuyts S
    Oncol Rep; 2009 Feb; 21(2):507-13. PubMed ID: 19148529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter hypermethylation using 24-gene array in early head and neck cancer: better outcome in oral than in oropharyngeal cancer.
    Noorlag R; van Kempen PM; Moelans CB; de Jong R; Blok LE; Koole R; Grolman W; van Diest PJ; van Es RJ; Willems SM
    Epigenetics; 2014 Sep; 9(9):1220-7. PubMed ID: 25147921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma.
    Chen K; Sawhney R; Khan M; Benninger MS; Hou Z; Sethi S; Stephen JK; Worsham MJ
    Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1131-8. PubMed ID: 18025318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of MS-MLPA in DNA methylation profiling in primary laryngeal squamous cell carcinoma.
    López F; Sampedro T; Llorente JL; Domínguez F; Hermsen M; Suárez C; Alvarez-Marcos C
    Oral Oncol; 2014 Apr; 50(4):291-7. PubMed ID: 24444674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profile of nasopharyngeal carcinoma: analysing tumour suppressor gene promoter hypermethylation by multiplex ligation-dependent probe amplification.
    Ooft ML; van Ipenburg J; van Loo R; de Jong R; Moelans C; Braunius W; de Bree R; van Diest P; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
    J Clin Pathol; 2018 Apr; 71(4):351-359. PubMed ID: 28893862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive correlation of tissue inhibitor of metalloproteinase-3 and death-associated protein kinase hypermethylation in head and neck squamous cell carcinoma.
    Nayak CS; Carvalho AL; Jeronimo C; Henrique R; Kim MM; Hoque MO; Chang S; Jiang WW; Koch W; Westra W; Sidransky D; Califano J
    Laryngoscope; 2007 Aug; 117(8):1376-80. PubMed ID: 17592394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
    Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
    Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppressor activity and inactivation of galanin receptor type 2 by aberrant promoter methylation in head and neck cancer.
    Misawa Y; Misawa K; Kanazawa T; Uehara T; Endo S; Mochizuki D; Yamatodani T; Carey TE; Mineta H
    Cancer; 2014 Jan; 120(2):205-13. PubMed ID: 24122450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demethylation treatment restores hic1 expression and impairs aggressiveness of head and neck squamous cell carcinoma.
    Brieger J; Pongsapich W; Mann SA; Hedrich J; Fruth K; Pogozelski B; Mann WJ
    Oral Oncol; 2010 Sep; 46(9):678-83. PubMed ID: 20729134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to global mining of aberrantly methylated promoter sites in squamous head and neck cancer.
    Worsham MJ; Chen KM; Stephen JK; Havard S; Benninger MS
    Otolaryngol Head Neck Surg; 2010 Jul; 143(1):116-21, 121.e1-19. PubMed ID: 20620629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent promoter hypermethylation of tumor-related genes in head and neck squamous cell carcinoma.
    Steinmann K; Sandner A; Schagdarsurengin U; Dammann RH
    Oncol Rep; 2009 Dec; 22(6):1519-26. PubMed ID: 19885608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promoter methylation in head and neck tumorigenesis.
    Stephen JK; Chen KM; Havard S; Harris G; Worsham MJ
    Methods Mol Biol; 2012; 863():187-206. PubMed ID: 22359294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of promoter hypermethylation detection in body fluids as a screening/diagnosis tool for head and neck squamous cell carcinoma.
    Carvalho AL; Jeronimo C; Kim MM; Henrique R; Zhang Z; Hoque MO; Chang S; Brait M; Nayak CS; Jiang WW; Claybourne Q; Tokumaru Y; Lee J; Goldenberg D; Garrett-Mayer E; Goodman S; Moon CS; Koch W; Westra WH; Sidransky D; Califano JA
    Clin Cancer Res; 2008 Jan; 14(1):97-107. PubMed ID: 18172258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the methylation profile of exfoliated cell samples from patients with head and neck squamous cell carcinoma.
    Longo AL; Rettori MM; de Carvalho AC; Kowalski LP; Carvalho AL; Vettore AL
    Head Neck; 2014 May; 36(5):631-7. PubMed ID: 23595968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene promoter-associated CpG island hypermethylation in squamous cell carcinoma of the tongue.
    Bhat S; Kabekkodu SP; Jayaprakash C; Radhakrishnan R; Ray S; Satyamoorthy K
    Virchows Arch; 2017 Apr; 470(4):445-454. PubMed ID: 28255813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.